Your browser doesn't support javascript.
loading
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.
Chiang, Hsueh-Chien; Lee, Yang-Cheng; Chang, Ting-Tsung; Lin, Yih-Jyh; Wu, Hung-Tsung; Wang, Chung-Teng; Chen, Chiung-Yu; Chen, Po-Jun; Hsieh, Ming-Tsung; Lin, Sheng-Hsiang; Chen, Shang-Hung; Chuang, Chiao-Hsiung; Wu, I-Chin; Hong, Tzu-Chun; Wu, Juei-Seng; Han, Meng-Zhi; Chen, Wei-Ting; Chiang, Chien-Ming; Hung, Kuan-Kai; Kuo, Hsin-Yu.
Afiliación
  • Chiang HC; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Lee YC; Departments of Internal Medicine, Tainan Municipal Hospital, Tainan 70103, Taiwan.
  • Chang TT; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Lin YJ; Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
  • Wu HT; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Wang CT; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Chen CY; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Chen PJ; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Hsieh MT; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Lin SH; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
  • Chen SH; Department of Public Health, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
  • Chuang CH; Biostatistics Consulting Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
  • Wu IC; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70456, Taiwan.
  • Hong TC; National Institute of Cancer Research, National Health Research Institutes, Tainan 70456, Taiwan.
  • Wu JS; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Han MZ; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Chen WT; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Chiang CM; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
  • Hung KK; Department of Internal Medicine, An Nan Hospital, China Medical University, Tainan 70965, Taiwan.
  • Kuo HY; Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70101, Taiwan.
Cancers (Basel) ; 15(3)2023 Jan 30.
Article en En | MEDLINE | ID: mdl-36765812

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Taiwán